Multi-pulse Skin Conditioning for Melasma and Pigmentation Disorders
- Treats symptoms of melasma and pigmentation disorders
- Rejuvenated, tighter and more youthful skin
- An innovative 4-step approach
- Minimally invasive
- Long-term results
Melasma is a complex condition that has long been difficult to treat, with improvements in most cases sustainable only for short periods of time. The patented MaQX Clear® procedure with the StarWalker® MaQX system is a multifactorial approach that not only treats hyperpigmentation symptoms, but is also believed to have beneficial effects on the vascular component of melasma.
How does MaQX Clear® work?
The 1st step applies Q-s Nd:YAG pulses with MaQX1, which delivers a subcellular photoacoustic effect oriented to the destruction of melanosomes and the fragmentation of dermal melanin.
The 2nd step uses low-fluence, short FRAC3® pulses, which research suggests may be beneficial for treating the microvascular components that cause erythema.
The 3rd step requires the use of the patented FracTAT® technology for fractional non-ablative and ablative treatments with the purpose to stimulate the exchange of keratinocytes and provide non-thermal rejuvenation of the tissue.
The 4thstep consists of the application of the Nd:YAG VERSA mode if vascular lesions are visible. This penetrates to a depth of 5-6 mm into the skin, allowing for highly effective removal of the lesions.
For optimal results, several treatments (4-8) are needed. The final result is a visible reduction in melasma and other pigmentation disorders as well as rejuvenated, tighter and more youthful skin. Patients report up to 1 year clearance for melasma and high satisfaction with the results. In a study conducted by Drs. Sebastian and Julio Cesar Velez Ocampo et. al. (see Scientific & Clinical Research tab) 94.8% of the patients maintained their clearance of melasma at the 6-month follow-up, and 83.4% of the patients maintained their clearance for up to 1 year.